Zoledronat Osteo Sandoz 5 mg/100 ml
Zoledronat Osteo Sandoz 5 mg/100 ml is a medicine authorised by Swissmedic under authorisation number 62626. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 March 2012 and the authorisation is valid without a time limit. ATC code M05BA08 places the medicine in the group Drugs for treatment of bone diseases.
| Authorisation number | 62626 |
|---|---|
| Name | Zoledronat Osteo Sandoz 5 mg/100 ml |
| Full name | Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M05BA08 |
| First authorisation | 29 March 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Zoledronat Osteo Sandoz 5 mg/100 ml, Infusionslösung | B | 29 March 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | M05BA08 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Zoledronat Osteo Sandoz 5 mg/100 ml authorised in Switzerland?
Yes. Zoledronat Osteo Sandoz 5 mg/100 ml is authorised by Swissmedic under authorisation number 62626, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Zoledronat Osteo Sandoz 5 mg/100 ml have?
Zoledronat Osteo Sandoz 5 mg/100 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Zoledronat Osteo Sandoz 5 mg/100 ml?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.